Home > News > Archives > 2008 > Index

2008 News Trial indicates new anticoagulant and antidote could be safe, fast option for patients Screening older patients for HIV can be a cost-effective health tool Heart failure patients overestimate their life span Despite treatment delays, off-hour heart attack patients don't have increased risk of death Despite treatment delays, off-hour heart attack patients don't have increased risk of death Research about coronary stents does not always disclose authors' financial stakes New drug-eluting stents not any safer than traditional stents, according to a new study JAMA editorial: Eric Peterson and Tracy Wang on preventive cardiology Trial participants not overly concerned by researchers' financial interests in trials Late-breaking clinical trial at ACC: Groundbreaking results from ACCOMPLISH ACC presentation: Making progress including women in clinical trials Late-breaking clinical trial at ACC: MEND-CABG II trial results Late-breaking clinical trial at ACC: Home Automated External Defibrillator Trial results ACC presentation: Warning signs of sudden cardiac death after heart attack Late-breaking clinical trial at ACC: Angioplasty at medical centers without on-site cardiac surgery Lack of NIH funding increases is straining younger researchers Pessimistic heart patients have higher risk of death Coronary bypass surgery effective but high-risk procedure for cardiogenic shock patients More elderly Americans are living with heart failure Acute hypertension patients don't receive enough follow-up Drug used in cardiac surgery increases mortality rate, DCRI researchers confirm Inaugural Class of Global Health Residency Program Announced New drug could minimize damage from heart attack treatment Blood clot treatment puts patients at greater risk of decreased level of platelets DCRI researchers complete first study on anti-clotting drugs for children Lower doses of aspirin are safer and as effective Global blood transfusion patterns raise questions

© 2003-2008 Duke Clinical Research Institute.